Fig. 1 · Structure
Documents & Downloads
WYC-210
Tazarotene Derivative
WYC-210 is a Tazarotene derivative that functions as a retinoid compound exhibiting reduced anticancer activity. This versatile compound contains an alkyne functional group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions. Its applications in click chemistry make it valuable for bioconjugation and the synthesis of complex molecular structures in various research settings.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2131803-93-3 |
| Applications | Tazarotene Derivative |
| Formula | C18H16N2O3S |
| Molecular Weight | 340.40 |
| SMILES | O=C(C1=CN=C(C#CC2=CC=C3C(C(C)(C)CCS3=O)=C2)N=C1)O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.